DK0556256T3 - Aerosolmedikamenter - Google Patents

Aerosolmedikamenter

Info

Publication number
DK0556256T3
DK0556256T3 DK91919751.7T DK91919751T DK0556256T3 DK 0556256 T3 DK0556256 T3 DK 0556256T3 DK 91919751 T DK91919751 T DK 91919751T DK 0556256 T3 DK0556256 T3 DK 0556256T3
Authority
DK
Denmark
Prior art keywords
propellant
cosolvent
aerosol medications
aerosol
medications
Prior art date
Application number
DK91919751.7T
Other languages
Danish (da)
English (en)
Inventor
Anthony James Taylor
Patricia Kwong Phieu Burnell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10685109&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0556256(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK0556256T3 publication Critical patent/DK0556256T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DK91919751.7T 1990-11-09 1991-11-07 Aerosolmedikamenter DK0556256T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909024365A GB9024365D0 (en) 1990-11-09 1990-11-09 Medicaments

Publications (1)

Publication Number Publication Date
DK0556256T3 true DK0556256T3 (da) 1995-11-06

Family

ID=10685109

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91919751.7T DK0556256T3 (da) 1990-11-09 1991-11-07 Aerosolmedikamenter

Country Status (11)

Country Link
EP (1) EP0556256B1 (ja)
JP (1) JP3210012B2 (ja)
AT (1) ATE127013T1 (ja)
AU (1) AU660952B2 (ja)
CA (1) CA2094726C (ja)
DE (1) DE69112637T2 (ja)
DK (1) DK0556256T3 (ja)
ES (1) ES2078551T3 (ja)
GB (1) GB9024365D0 (ja)
GR (1) GR3018172T3 (ja)
WO (1) WO1992008446A1 (ja)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776434A (en) 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
DE69231991T2 (de) 1991-06-10 2002-04-04 Schering Corp Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
DE4132176C2 (de) * 1991-09-27 1997-03-13 Ig Spruehtechnik Gmbh Dosieraerosole mit Isobutan als Treibmittel
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
AU663905B2 (en) 1991-12-12 1995-10-26 Glaxo Group Limited Medicaments
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
ATE128350T1 (de) * 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
ATE150296T1 (de) * 1991-12-18 1997-04-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
TW402506B (en) 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US5747445A (en) * 1993-06-24 1998-05-05 Astra Aktiebolag Therapeutic preparation for inhalation
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
US5830853A (en) * 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
DE4323636A1 (de) * 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
CA2183557A1 (en) * 1994-03-14 1995-09-21 Mou-Ying Fu Lu Aerosol drug formulations containing vitamin e
US6165976A (en) 1994-06-23 2000-12-26 Astra Aktiebolag Therapeutic preparation for inhalation
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5747001A (en) * 1995-02-24 1998-05-05 Nanosystems, L.L.C. Aerosols containing beclomethazone nanoparticle dispersions
ATE274341T1 (de) * 1995-02-24 2004-09-15 Elan Pharma Int Ltd Nanopartikel-dispersionen enthaltende aerosole
DE69622166T2 (de) * 1995-04-14 2003-04-03 Smithkline Beecham Corp Dosierinhalator für albuterol
HUP9800641A3 (en) * 1995-04-14 2001-04-28 Glaxo Wellcome Inc Res Triangl Metered dose inhaler for beclomethasone dipropionate
NZ306280A (en) * 1995-04-14 1999-07-29 Glaxo Wellcome Inc Metered dose inhaler for salmeterol
PL180895B1 (pl) 1995-04-14 2001-04-30 Glaxo Wellcome Inc Inhalator z dozymetrem
GB9526392D0 (en) * 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
AU774250B2 (en) * 1997-06-13 2004-06-24 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
PL343491A1 (en) * 1998-04-18 2001-08-27 Glaxo Group Ltd Pharmaceutical aerosol formulation
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
JP2002541183A (ja) * 1999-04-14 2002-12-03 グラクソ グループ リミテッド 医薬用エアゾール製剤
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
EP2298279B1 (en) 2000-11-30 2018-11-14 Vectura Limited Pharmaceutical compositions for inhalation
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
EP1458360B1 (en) 2001-12-19 2011-05-11 Novartis AG Pulmonary delivery of aminoglycosides
EP2425820B1 (en) 2007-02-11 2015-04-08 MAP Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations

Also Published As

Publication number Publication date
GR3018172T3 (en) 1996-02-29
DE69112637T2 (de) 1996-02-08
JP3210012B2 (ja) 2001-09-17
WO1992008446A1 (en) 1992-05-29
AU8877891A (en) 1992-06-11
EP0556256A1 (en) 1993-08-25
DE69112637D1 (de) 1995-10-05
ES2078551T3 (es) 1995-12-16
CA2094726A1 (en) 1992-05-10
GB9024365D0 (en) 1991-01-02
AU660952B2 (en) 1995-07-13
JPH06501700A (ja) 1994-02-24
ATE127013T1 (de) 1995-09-15
EP0556256B1 (en) 1995-08-30
CA2094726C (en) 2002-01-15

Similar Documents

Publication Publication Date Title
DK0556256T3 (da) Aerosolmedikamenter
GEP20002140B (en) Pharmaceutical Aerosol Composition
ES2078550T3 (es) Aerosol que contiene medicamentos.
PT98105A (pt) Processo para a preparacao de formulacoes em aerossol contendo como propulsor 1,1,1,2-tetrafluoroetano
PT81839A (en) Drug-containing chlorofluorocarbon aerosol propellent formulation
DE69111426T2 (de) Treibmittelzubereitungen.
FI20011187A (fi) Antigeenin kanssa käytettäväksi tarkoitettuja koostumuksia
PT918507E (pt) Formulacoes em aerossol
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
AU8050791A (en) Compositions and methods for the controlled release of soluble active substances
CA2125665A1 (en) Medicaments
DK0708772T3 (da) Imidazo[4,5,-c]pyridin-4-aminer
DE69131867D1 (de) Anwendung von löslichen fluorhaltigen Tensiden zur Herstellung von Aerosol-Präparaten mit dosierter Abgabe
ATE131730T1 (de) Nukleosidanalogen enthaltende antiviren- zubereitungen
ES2112308T3 (es) Composiciones de glifosatos y su uso.
AU7748891A (en) Azeotrope-like compositions of 1,1-dichloro-1-fluoroethane, 1,2-dichloroethylene and optionally an alkanol
DE3685410D1 (de) Filmbildendes mittel zur topischen anwendung.
IT9021157A0 (it) "catalizzatore di deidroisomerizzazione e suo uso nella preparazione di isobutene da n-butano"
JPS52125630A (en) Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JPS523023A (en) Preparation of amino acid ester of organopolysiloxane
DE68913997T2 (de) Fluorierte flavon-essigsäure.
IL54041A (en) Pharmaceutical compositions for enteral or vaginal application comprising the active ingredient and a nonionic surfactant
JPS5726610A (en) Emulsified composition for aerosol type preventing agent of hand roughness
MX9101107A (es) Composicion que contiene un agente opacificante y metodo para su preparacion
IT8919370A0 (it) Metodo per ridurre gli effetti irritativi locali di preparazione farmaceutiche e composizioni cosi' ottenute.